Sudocrem man Stafford is on board for Amryt deal

Home
About Us
Selected Transactions
Raglan IPO Projects
- Raglan Pharmaceutical & Life Science Projects
- Raglan Natural Resources
News
Contact us

Open Orphan subsidiary develops human study for malaria
Surprise! Pfizer jumps the queue and leaps into RSV vax contention as COVID helps turbocharge work
The Executive Chairman of Open Orphan plc (LON:ORPH), Cathal Friel, Just Bought 2.5% More Shares
BRIEF—COVID-19 human challenge study to expand
Open Orphan launches infectious disease spinout
Our flu drug is not to be sniffed at, says Poolbeg Pharma chief Jeremy Skillington